NEW YORK (GenomeWeb) – Monsanto announced today that it has licensed a CRISPR technology platform from Korean biotechnology company ToolGen with the intention of developing agricultural products.

The global license provides Monsanto with access to ToolGen's comprehensive suite of CRISPR intellectual property for use in plants. The agreement will also expand Monsanto's portfolio of gene editing tools, which the company plans to use to develop improved and sustainable crops.

Specific terms of the deal were not disclosed.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.